News & Analysis on Clinical Trial Services & Contract Research And Development
The UK launch of Eli Lilly’s pre-filled insulin device Humalog KwikPen offers the country’s 800,000 insulin-dependant diabetics a simplified treatment option, according to company development director Stuart Breslin.
BASF introduced new catalysts designed to replace environmentally-unfriendly alternatives based on lead at the CPhI show in Frankfurt last week.
BioVigilant says that two type V DMFs for its IMD-A rapid microbial detection system, which it has filed with the US FDA, can now be referenced by clients hoping to use it in drug manufacture, potentially reducing review times.
Drug delivery specialist Encap hopes that a recently completed £3m (€3.9m) expansion of its production facility, which allows it make high potency drugs, will help it attract a broader range of manufacturing contracts.
Packaging firm Chesapeake has become a visible casualty of the current economic climate, with the New York Stock Exchange (NYSE) suspending trading of its shares.
India-based Piramal Healthcare has extended the range of early phase drug product development and manufacturing on offer at its Morpeth, UK facility.
Contract research organisation Encorium has bought $250,000 of its own stock in a bid to stabilise its share price, which has been in steep decline in recent weeks.